Press release
Retinal Vein Occlusion Market Research Report- Growth in Future with Market Size, Share, Growth, and Key Companies Analysis by DelveInsight
Retinal Vein Occlusion Market
DelveInsight's "Retinal Vein Occlusion (RVO) - Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Retinal Vein Occlusion (RVO) , historical and forecasted epidemiology as well as the Retinal Vein Occlusion (RVO) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Get a free Sample Report: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Retinal Vein Occlusion Market Reports key facts-
1. As per study by Laouri et al. titled, "The burden of disease of retinal vein occlusion: review of the literature," the age and sex standardized prevalence was found to be 5.20 (per 1000) for any RVO, 4.42 for BRVO, and 0.80 for CRVO in the population aged ≥30 years.
2. The study titled "Prevalence of Retinal Vein Occlusion in Europe: A Systematic Review and Meta-Analysis" conducted by Li et al., found the prevalence of RVO in Europe to be 0.7% in persons aged 55 years and older based on the examination of individuals from four prevalence studies.
3. As per The European Society of Retina Specialists (EURETINA) more than 1.1 million people over the age of 55 years are currently affected by a RVO in the EU with 15-25% due to CRVO and 75-80% due to BRVO. This corresponds to a prevalence of RVO in either eye of 0.7%.
4. According to the study conducted by Yasuda et al., titled "Prevalence and Systemic Risk Factors for Retinal Vein Occlusion in a General Japanese Population: The Hisayama Study," the prevalence of RVO was 2.1% (2.0% for branch RVO and 0.2% for central RVO) in japan. After adjustment for age and sex, it was found that systolic and diastolic blood pressures, hypertension, and hematocrit were significantly associated with RVO.
Get a free Sample Report: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of Retinal Vein Occlusion Market Report:
• The report covers the descriptive overview of Retinal Vein Occlusion (RVO) , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Retinal Vein Occlusion (RVO) epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Retinal Vein Occlusion (RVO) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of Retinal Vein Occlusion (RVO) market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Retinal Vein Occlusion (RVO) market
Get a free Sample Report: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Retinal Vein Occlusion (RVO) is an interruption of the normal venous drainage from the retinal tissue. Either the central vein or one of its branches can become occluded. Uncommonly, the occlusion can occur in a vein that drains half of the retina. This is referred to as a hemiretinal vein occlusion (HRVO).
Request for Sample Page: https://www.delveinsight.com/sample-request/retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Retinal Vein Occlusion Epidemiology
The Retinal Vein Occlusion (RVO) epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Retinal Vein Occlusion (RVO) epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Retinal Vein Occlusion (RVO) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Get a free Sample Report: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of key Retinal Vein Occlusion companies
• Panoptes Pharma
• Outlook Therapeutics
• Graybug Vision
• Kodiak Sciences
• And Many Others
Name of Retinal Vein Occlusion drugs covered
• PaniJect
• ONS-5010
• GB-102
• KSI-301
• And Many Others
Request for Sample Page: https://www.delveinsight.com/sample-request/retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of content:
1. Key Insights
2. Executive Summary of Retinal Vein Occlusion (RVO)
3. Competitive Intelligence Analysis for Retinal Vein Occlusion (RVO)
4. Retinal Vein Occlusion (RVO) : Market Overview at a Glance
5. Retinal Vein Occlusion (RVO) : Disease Background and Overview
6. Patient Journey
7. Retinal Vein Occlusion (RVO) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Retinal Vein Occlusion (RVO) Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Retinal Vein Occlusion (RVO): Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Retinal Vein Occlusion (RVO)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Get a free Sample Report: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Related Reports:
3D Cardiac Mapping System Market
https://www.delveinsight.com/report-store/3d-cardiac-mapping-system-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Acanthamoeba Keratitis Market
https://www.delveinsight.com/report-store/acanthamoeba-keratitis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Adult Growth Hormone Deficiency Market
https://www.delveinsight.com/report-store/adult-growth-hormone-deficiency-aghd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Advanced Cancer Pain Management Market
https://www.delveinsight.com/report-store/advanced-cancer-pain-management-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Apheresis Market
https://www.delveinsight.com/report-store/apheresis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Arteriovenous fistula Market
https://www.delveinsight.com/report-store/arteriovenous-fistula-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Automated external defibrillators (AEDs) Market
https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Balloon Catheters Market
https://www.delveinsight.com/report-store/balloon-catheters-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Calciphylaxis Market
https://www.delveinsight.com/report-store/calciphylaxis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cerebral Aneurysm Market
https://www.delveinsight.com/report-store/cerebral-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Chronic Idiopathic Urticaria Market
https://www.delveinsight.com/report-store/chronic-idiopathic-urticaria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Retinal Vein Occlusion Market Research Report- Growth in Future with Market Size, Share, Growth, and Key Companies Analysis by DelveInsight here
News-ID: 2653118 • Views: …
More Releases from DelveInsight Business Research
Peripheral T-Cell Lymphoma (PTCL) Market Analysis 2034 - Competitive Landscape, …
The Peripheral T-Cell Lymphoma (PTCL) Market across the 7MM was valued at approximately USD 680 million in 2020, and it is projected to experience steady growth by 2034.
Peripheral T-Cell Lymphoma (PTCL) Market Overview
As of 2023, the United States held the largest share of the PTCL therapeutics market within the 7MM, reaching a valuation of around USD 500 million, followed by Japan. Newly diagnosed patients are generally managed with anthracycline-based chemotherapy…
Nontuberculous Mycobacterial Infection Market Analysis 2034 - Competitive Landsc …
In 2023, the Nontuberculous Mycobacterial (NTM) Infections Market in the United States was valued at around USD 360 million, and it is projected to grow throughout the 2024-2034 forecast period.
Nontuberculous Mycobacterial Market Overview
The NTM infections market is anticipated to expand consistently between 2024 and 2034, fueled by advancements in diagnostics, the introduction of novel therapies, and growing disease awareness. The aging population, which is more susceptible to NTM infections, continues…
Lupus Nephritis Market Analysis 2034 - Competitive Landscape, Clinical Trials, M …
The Lupus Nephritis (LN) market was valued at approximately USD 1.8 billion in 2024 and is projected to expand steadily from 2025 to 2034, driven by the introduction of emerging therapies across the seven major markets (7MM).
Lupus Nephritis Market Summary
In Japan, the Lupus Nephritis market size was around USD 49 million in 2024, and it is anticipated to grow throughout the forecast period (2025-2034). Lupus Nephritis, a serious complication of…
Sjogren's Syndrome Market Outlook 2034 - Clinical Trials, Market Size, Medicatio …
Prominent Sjogren's syndrome companies include Rise Therapeutics, Bristol-Myers Squibb, Resolve Therapeutics, Novartis, Horizon Therapeutics, Dompe Farmaceutici, Horizon Therapeutics (Amgen), Sylentis, OSE Immunotherapeutics, Servier, Johnson & Johnson, and several others.
Sjogren's Syndrome Market Summary
In 2023, the Sjogren's syndrome market size across the seven major markets (7MM) was valued at approximately USD 1.9 billion and is expected to witness steady growth through 2034.
Sjogren's syndrome is an autoimmune disease that primarily disrupts the salivary…
More Releases for RVO
Retinal Vein Occlusion (RVO) Market is expected to reach USD 4.3 billion by 2034
Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy. It occurs when a blockage develops in the veins that carry blood away from the retina, leading to vision impairment, macular edema, and in some cases, retinal ischemia or neovascularization.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72291
The condition is classified into branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO). Risk…
Retinal Vein Occlusion Market to Surpass USD 5.5 Billion by 2034, Fueled by Regu …
The global retinal vein occlusion (RVO) market was valued at USD 2.8 billion in 2023 and is projected to experience a remarkable CAGR of 6.7% from 2024 to 2034, with an expected market value surpassing USD 5.5 billion by the end of 2034. This growth is attributed to factors such as rising awareness of the condition, increasing regulatory approvals for new treatments, and innovations in pharmacological therapies, including anti-VEGF drugs…
Retinal Vein Occlusion Market Set to Reach USD 5.5 Billion by 2034, Driven by In …
The global retinal vein occlusion (RVO) market was valued at USD 2.8 billion in 2023 and is projected to experience a remarkable CAGR of 6.7% from 2024 to 2034, with an expected market value surpassing USD 5.5 billion by the end of 2034. This growth is attributed to factors such as rising awareness of the condition, increasing regulatory approvals for new treatments, and innovations in pharmacological therapies, including anti-VEGF drugs…
Retinal Vein Occlusion (RVO) Market Size to Reach USD 4.65 Billion in 2032 Growi …
The global Retinal Vein Occlusion (RVO) market, valued at USD 2.46 billion in 2022, is projected to exhibit a rapid revenue Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period, according to a recent market research report. The rising prevalence of conditions such as diabetes and atherosclerosis, coupled with increased focus on the development of novel drugs for RVO treatment, are key factors propelling market growth.
Retinal Vein Occlusion…
Retinal Vein Occlusion (RVO) Market Size Worth USD 4.65 Billion 2032 | Emergen R …
The global Retinal Vein Occlusion (RVO) market size was USD 2.46 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.7% during the forecast period. A recent market research report has shed light on the flourishing trajectory of the global Retinal Vein Occlusion (RVO) treatment market. The report attributes this growth to various factors including the rising prevalence of diabetes and atherosclerosis, coupled with the…
Exploring the Growth Potential and Opportunities of the Retinal Vein Occlusion ( …
The latest published research the "Retinal Vein Occlusion (RVO) Market" report provides the overall growth and business outlook of the global industry. The assessment presented in the SMI research report gives thorough data and analysis of major important facets such as growth drivers, challenges, restraints, present and historical trends, and growth opportunities in the market. The report research covers valuable information on the business with insights, applications, and the industrial…
